Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 10.3010.5610.988.726.24

What is the latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS is 10.30 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202610.30
Mar202510.56
Mar202410.98
Mar20238.72
Mar20226.24

How is EV/Core EBITDA of BALAXI PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 10.3
-2.46
Mar2025 10.56
-3.83
Mar2024 10.98
25.92
Mar2023 8.72
39.74
Mar2022 6.24 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹123.3 Cr -1.9% -4.3% -50.8% Stock Analytics
ADANI ENTERPRISES ₹356,449.0 Cr -7.9% -11% 3.4% Stock Analytics
ADITYA INFOTECH ₹51,332.2 Cr 4.9% 9.4% 193% Stock Analytics
AEGIS LOGISTICS ₹48,722.3 Cr 2.2% 9.5% 57.1% Stock Analytics
PREMIER ENERGIES ₹40,628.7 Cr 0.8% -9.3% -15.2% Stock Analytics
REDINGTON ₹29,715.2 Cr -7.9% 1.7% 38.5% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-1.9%

-4.3%

-50.8%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses